| Literature DB >> 33108537 |
Tristan Celse1,2, Caroline Cazin1,2, Flore Mietton2, Guillaume Martinez1,3, Delphine Martinez2, Nicolas Thierry-Mieg4, Amandine Septier4, Catherine Guillemain5,6, Julie Beurois1, Antoine Clergeau7, Selima Fourati Ben Mustapha8, Mahmoud Kharouf8, Abdelali Zoghmar9, Ahmed Chargui10, Aline Papaxanthos11, Béatrice Dorphin12, Bernard Foliguet13, Chema Triki14, Christophe Sifer15, Dominique Lauton16, Gérard Tachdjian17, Gilles Schuler18, Hervé Lejeune19, Jacques Puechberty20, Julien Bessonnat21, Laurent Pasquier22, Lionel Mery23, Marine Poulain24, Myriam Chaabouni8, Nathalie Sermondade25, Rosalie Cabry26, Sebti Benbouhadja9, Ségolène Veau27, Cynthia Frapsauce28, Valérie Mitchell29, Vincent Achard30,31,32, Veronique Satre1,3, Sylviane Hennebicq1,21, Raoudha Zouari5, Christophe Arnoult1, Zine-Eddine Kherraf1,2, Charles Coutton1,3, Pierre F Ray33,34.
Abstract
Globozoospermia is a rare phenotype of primary male infertility inducing the production of round-headed spermatozoa without acrosome. Anomalies of DPY19L2 account for 50-70% of all cases and the entire deletion of the gene is by far the most frequent defect identified. Here, we present a large cohort of 69 patients with 20-100% of globozoospermia. Genetic analyses including multiplex ligation-dependent probe amplification, Sanger sequencing and whole-exome sequencing identified 25 subjects with a homozygous DPY19L2 deletion (36%) and 14 carrying other DPY19L2 defects (20%). Overall, 11 deleterious single-nucleotide variants were identified including eight novel and three already published mutations. Patients with a higher rate of round-headed spermatozoa were more often diagnosed and had a higher proportion of loss of function anomalies, highlighting a good genotype phenotype correlation. No gene defects were identified in patients carrying < 50% of globozoospermia while diagnosis efficiency rose to 77% for patients with > 50% of globozoospermia. In addition, results from whole-exome sequencing were scrutinized for 23 patients with a DPY19L2 negative diagnosis, searching for deleterious variants in the nine other genes described to be associated with globozoospermia in human (C2CD6, C7orf61, CCDC62, CCIN, DNAH17, GGN, PICK1, SPATA16, and ZPBP1). Only one homozygous novel truncating variant was identified in the GGN gene in one patient, confirming the association of GGN with globozoospermia. In view of these results, we propose a novel diagnostic strategy focusing on patients with at least 50% of globozoospermia and based on a classical qualitative PCR to detect DPY19L2 homozygous deletions. In the absence of the latter, we recommend to perform whole-exome sequencing to search for defects in DPY19L2 as well as in the other previously described candidate genes.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33108537 DOI: 10.1007/s00439-020-02229-0
Source DB: PubMed Journal: Hum Genet ISSN: 0340-6717 Impact factor: 4.132